Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes have?
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes published?
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes has 2013 year in the ScholarIQ index.
What is the open-access status of Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes?
Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes has closed oa status in the ScholarIQ index.
What is the DOI of Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes?
The DOI for Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes is on the source record.
What is the PMID of Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes?
The PMID for Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes is on the source record.
What is the OpenAlex record for Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes?
The OpenAlex for Acarbose plus metformin fixed-dose combination outperforms acarbose monotherapy for type 2 diabetes is on the source record.